Singapore: Japan-based Astellas Pharma and US-headquartered Ambit Biosciences are ending their collaboration for joint d...
Singapore: US-based Edison Pharmaceuticals has entered into a strategic alliance valued up to $4.295 billion with Japan'...
Singapore: US-based Gilead Sciences has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Dev...
Singapore: AnGes MG entered into a definitive agreement with Mitsubishi Tanabe Pharma for the exclusive marketing right...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: A research team at the tissue regeneration materials unit, National Institute for Materials Science (NIMS), s...
Singapore: Japan-based Astellas Pharma has received US FDA approval for Astagraf XL (tacrolimus extended-release capsule...
Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry ser...
Singapore: Pfizer and Mylan have signed a definitive agreement to establish an exclusive long-term strategic collaborati...
Singapore: Japanese firm Takara Bio has entered into an agreement with Invivoscribe Technologies to grant the latter lic...
Singapore: NuVasive, a medical device company focused on developing minimally disruptive surgical products and procedur...
Singapore: Medicago, a biopharmaceutical company focused on developing highly effective and competitive vaccines based o...
Singapore: US-based Kinetic Concepts (KCI) has launched ActiVAC Therapy System for in-patient use in Japan, which is a l...
Singapore: Terumo and Biosensors International announced an extension of their existing licensing agreements, under w...
Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to...
Singapore: Vital Connect recently announced that its wearable device HealthPatch MD has received approval for sale in th...
Singapore: USA-based Amgen, the world's largest independent biotech company, has expanded its strategic collaboration wi...
Singapore: Taiho Pharmaceutical submitted an application for approval of the manufacture and marketing of the novel oral...
Singapore: Eisai announced that its U.S. subsidiary has received approval from the U.S. Food and Drug Administration (F...
Singapore: Japan-based Arte and German company ProJect Pharmaceutics are working closely on the development of a new typ...
Singapore: Takeda Pharmaceutical Company and LigoCyte Pharmaceuticals, jointly announced that Takeda's wholly-owned sub...
Singapore: The 17th edition of BioJapan is all set to kick off from October 14, 2015 Pacifico Yokohama. Top industry pla...
Singapore: Takeda Pharmaceutical has entered into a partnership with Resolve Therapeutics to develop compounds for the t...
Singapore: LEO Pharma plans to establish five long-term, strategic research collaborations in four countries by the end ...
Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the ...
